Newsroom

Temple Health is one of 42 health systems nationwide selected to participate in the Patient-Centered Outcomes Research Institute (PCORI)’s Health Systems Implementation Initiative (HSII) to accelerate the uptake of practice-changing research results in clinical care to improve quality and patient outcomes. The goal of this multi-year PCORI initiative is to help cut the estimated 17-year lag between publication of medical research results and their widespread implementation in real-world practice settings.

Scientists have long known that leukemia cells accumulate a great deal of spontaneous DNA damage, far more than normal blood cells. Unfortunately, these cancer cells also have an uncanny ability to repair DNA damage and survive, so they can continue spreading throughout the body.

Pedro Torres-Ayuso, PhD, an assistant professor in the Department of Cancer and Cellular Biology at the Lewis Katz School of Medicine at Temple University and the Cancer Signaling and Microenvironment research program at Fox Chase Cancer Center, recently received a grant that will be incorporated into the prestigious Specialized Program of Research Excellence (SPORE) for head and neck cancer held by Fox Chase Cancer Center.